Leica Biosystems Acquires Cell IDx

Leica Biosystems to Acquire StatLab Medical Products From Linden Capital Partners and Audax Private Equity

July 14, 2026

Medical Devices

Leica Biosystems, a Danaher company, signed a definitive agreement to acquire StatLab Medical Products. StatLab is currently owned by Linden Capital Partners and Audax Private Equity, and the transaction is subject to customary closing conditions. Financial terms were not disclosed and the deal was expected to close by the end of 2026.

Eurobio Scientific Acquires CareDx Lab Products Division

April 16, 2026

Healthcare Services

Eurobio Scientific entered into a definitive agreement to acquire CareDx’s Lab Products transplant lab products division for €145 million (about $170 million) in cash. The deal will integrate the acquired Lab Products portfolio into Eurobio’s GenDx operations and is intended to expand GenDx’s comprehensive transplantation IVD workflow, from pre-transplant HLA typing to post-transplant monitoring solutions.

Agilent Technologies Acquires Biocare Medical

March 9, 2026

Medical Devices

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.

Cell Microsystems Acquires Fluxion Biosciences

August 23, 2023

Medical Devices

Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

IDEX Corporation Acquires Microfluidics International Corporation

January 11, 2011

Medical Devices

IDEX Corporation agreed to acquire Microfluidics International Corporation in an all-cash transaction valued at $1.35 per share, expected to close in Q1 2011. The acquisition adds Microfluidics' Microfluidizer high-shear fluid processors and nanomaterials processing capabilities to IDEX's Fluid and Metering segment to expand its pharmaceutical and particle-processing product offerings.